Alpenglow Biosciences

📍 Seattle, United States🗓 Founded 2018👥 25 employees💰 Last funded Jan 2023
Founded in 2018, Seattle-based Alpenglow Biosciences is a privately held, early-stage life sciences company focused on accelerating drug development and improving clinical diagnostics with AI-enabled, 3D imaging technology. Our platform solution provides new spatial biology insights with greater accuracy by digitizing entire tissues while keeping samples intact for additional analysis. Alpenglow partners with pharmaceutical companies to develop better therapeutics and greater understanding of biodistribution, mechanism of action, and rank ordering of potential candidates using our patented technology. Five of the top 10 pharma companies work with Alpenglow to accelerate development timelines, gain new insights, and improve therapeutic success. We are hiring talented individuals for roles in business development, wet lab, hardware, and software.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Alpenglow Biosciences?
Alpenglow Biosciences has 1 investors on record on gritt.io, 1 mid-stage.
When did Alpenglow Biosciences last raise funding?
The most recent investment in Alpenglow Biosciences recorded on gritt.io was in January 2023.
When was Alpenglow Biosciences founded?
Alpenglow Biosciences was founded in 2018.
What industry is Alpenglow Biosciences in?
Alpenglow Biosciences operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Alpenglow Biosciences based?
Alpenglow Biosciences is headquartered in Seattle, United States.